The Philips CavaClear Laser Sheath earned the agency’s breakthrough device designation back in July.

The direct oral anticoagulant is now approved for 11 different indications. 

This latest analysis tracked more than 300 patients for a median follow-up period of nearly five years.

The report, primarily focused on compensation data in the United States, also examined how COVID-19 continues to impact the country's workforce. 

The study found that frail patients with AFib are less likely to be treated with DOAC therapy.

Post-TAVR high-degree atrioventricular block and complete heart block often lead to the implantation of a permanent pacemaker.

The system was designed to treat both pediatric and adult patients.

The small study, published in the Journal of the American College of Cardiology, compared patient outcomes associated with metoprolol and a placebo. 

Optum surveyed more than 500 senior health execs from top hospitals, health plans, employers and other organizations for its fourth annual survey.